Long Term Data Looks Good for Spinal Muscular Atrophy Gene Therapy Zolgensma
According to a story from Benzinga, the Novartis Company AveXis recently announced the results of long term studies testing the impact of Zolgensma, a gene therapy treatment that was approved…